PCN20 COSTS OF TREATING ADVANCED NON-SMALL-CELL LUNG CANCER IN SPAIN USING GEMCITABINE IN COMBINATION WITH CISPLATIN- A COMPARISON WITH OTHER 2ND GENERATION NOVEL AGENTS
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65754-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)65754-3/fulltext
Title :
PCN20 COSTS OF TREATING ADVANCED NON-SMALL-CELL LUNG CANCER IN SPAIN USING GEMCITABINE IN COMBINATION WITH CISPLATIN- A COMPARISON WITH OTHER 2ND GENERATION NOVEL AGENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65754-3&doi=10.1016/S1098-3015(10)65754-3
First page :
Section Title :
Open access? :
No
Section Order :
122